Phase 2 Study of ET-743 in Persistent or Recurrent Endometrial Carcinoma

This study has been completed.

Study NCT00050440 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: December 9, 2002 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given